Ibutamoren (MK-677) Ultima Pharmaceuticals: Compound Profile
Ibutamoren (MK-677) is a non-peptide growth hormone secretagogue developed by Reverse Pharmacology for in-vitro research applications. This compound functions as an oral ghrelin receptor agonist, distinguishing it from traditional peptide-based growth hormone releasing compounds. Researchers at Stroid UK Shop can investigate this compound’s unique mechanism of action and oral bioavailability characteristics. MK-677 represents a significant advancement in growth hormone secretagogue research, offering researchers a non-peptide alternative for examining growth hormone pathway modulation. Ultima Pharmaceuticals has formulated this research compound to meet laboratory standards for consistency and analytical verification. The compound’s classification as a growth hormone secretagogue places it within the broader category of metabolic modulators, though it specifically targets ghrelin receptor pathways rather than traditional anabolic pathways investigated with SARMs.
Laboratory Applications
Research institutions study MK-677’s mechanism as a ghrelin receptor agonist in various experimental models. The compound stimulates pulsatile growth hormone release without affecting cortisol levels in preclinical research settings. Scientists investigate its oral bioavailability characteristics, which distinguish it from peptide-based compounds that typically require injection protocols. Phase II clinical studies have examined this compound for growth hormone deficiency and sarcopenia research applications. Laboratory researchers evaluate its effects on IGF-1 expression and related metabolic pathways. The compound’s ability to mimic ghrelin receptor activation makes it valuable for studying appetite regulation and growth hormone axis function. Researchers often compare MK-677’s activity profile with traditional peptides to understand mechanistic differences between peptide and non-peptide growth hormone secretagogues. Studies examine its pharmacokinetic properties and duration of action in various experimental models. The compound serves as a research tool for investigating the relationship between ghrelin signalling and growth hormone secretion patterns in controlled laboratory environments.
Product Specifications
| Chemical Name | 2-amino-N-[2-[1-(methylsulfonyl)spiro[2H-indole-3,4′-piperidine]-1′-yl]-2-oxo-ethyl]-2-methylpropanamide |
|---|---|
| CAS Number | 159634-47-6 |
| Molecular Formula | C₂₇H₃₆N₄O₅S |
| Molecular Weight | 528.66 g/mol |
| Manufacturer | Ultima Pharmaceuticals |
| Storage Conditions | Room temperature, dry environment |
| Solubility | DMSO, ethanol |
| Stability | Stable under recommended storage conditions |
Researchers studying growth hormone secretagogue compounds can access this Ultima Pharmaceuticals formulation through our Ibutamoren research category. The compound’s specifications make it suitable for various analytical and biological research applications requiring consistent quality standards.
Research Compliance
This Ibutamoren (MK-677) product is manufactured by Ultima Pharmaceuticals exclusively for in-vitro research purposes. The compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper laboratory protocols, safety measures, and regulatory compliance when handling this research chemical. All studies involving this compound should be conducted by qualified personnel in appropriate research facilities with proper ventilation and safety equipment.
